Comparative in vitro activity of BAY 12-8039 and five other antimicrobial agents against anaerobic bacteria
- 1 March 1998
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 17 (3) , 193-195
- https://doi.org/10.1007/bf01691117
Abstract
The in vitro activity of BAY 12-8039 against 360 anaerobic clinical isolates was determined by the agar dilution method and compared to that of five other antimicrobial agents. BAY 12-8039 and imipenem were the most active agents tested. The following MIC90 values were determined for BAY 12-8039Peptostreptococcus spp. (50 isolates), 1 mg/l;Propionibacterium acnes (30 isolates), 0.25 mg/l;Clostridium perfringens (30 isolates), 0.5 mg/l;Clostridium difficile (50 isolates), 2 mg/l;Bacteroides fragilis (50 isolates), 1 mg/l;non- fragilis Bacteroides, Porphyromonas, andPrevotella spp. (100 isolates), 2 mg/l; andFusobacterium spp. (50 isolates), 0.25 mg/l. The results of the present study show that BAY 12-8039 may be useful in the treatment and prophylaxis of anaerobic infections.Keywords
This publication has 11 references indexed in Scilit:
- In vitro activity of Bay 12-8039, a new 8-methoxyquinoloneAntimicrobial Agents and Chemotherapy, 1997
- Comparison of the in vitro activities of Bay 12-8039, a new quinolone, and other antimicrobials against clinically important anaerobesAntimicrobial Agents and Chemotherapy, 1997
- In vitro activity of BAY 12-8039, a new fluoroquinoloneAntimicrobial Agents and Chemotherapy, 1997
- In Vitro Activity of Quinolones and Other Antimicrobial Agents Against Anaerobic BacteriaClinical Infectious Diseases, 1996
- In vitro Activity of BAY 12-8039, a New 8-MethoxyquinoloneChemotherapy, 1996
- Anaerobic infections in humans: an overviewAnaerobe, 1995